BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 29907148)

  • 1. A case of Metaplastic atrophic gastritis in immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) syndrome.
    Luo Y; Chen J; Fang Y; Lou J; Yu J
    BMC Pediatr; 2018 Jun; 18(1):191. PubMed ID: 29907148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked Syndrome in Two Siblings: Same Mutation But Different Clinical Manifestations at Onset.
    Karagüzel G; Polat R; Abul MH; Cebi AH; Orhan F
    J Clin Res Pediatr Endocrinol; 2022 Aug; 14(3):361-365. PubMed ID: 34044499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity.
    Gambineri E; Perroni L; Passerini L; Bianchi L; Doglioni C; Meschi F; Bonfanti R; Sznajer Y; Tommasini A; Lawitschka A; Junker A; Dunstheimer D; Heidemann PH; Cazzola G; Cipolli M; Friedrich W; Janic D; Azzi N; Richmond E; Vignola S; Barabino A; Chiumello G; Azzari C; Roncarolo MG; Bacchetta R
    J Allergy Clin Immunol; 2008 Dec; 122(6):1105-1112.e1. PubMed ID: 18951619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mutation and unusual clinical features in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome.
    Bae KW; Kim BE; Choi JH; Lee JH; Park YS; Kim GH; Yoo HW; Seo JJ
    Eur J Pediatr; 2011 Dec; 170(12):1611-5. PubMed ID: 21979562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune dysregulation, polyendocrinopathy and enteropathy, X-linked (IPEX) syndrome due to a mutation in FOXP3, modified by a pathogenic variant in SON (SON DNA-binding protein).
    Kylat RI; Stanley K; Simon S; Erickson RP
    J Appl Genet; 2023 Feb; 64(1):141-144. PubMed ID: 36175752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and molecular findings in IPEX syndrome.
    Myers AK; Perroni L; Costigan C; Reardon W
    Arch Dis Child; 2006 Jan; 91(1):63-4. PubMed ID: 16371377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity.
    Ochs HD; Gambineri E; Torgerson TR
    Immunol Res; 2007; 38(1-3):112-21. PubMed ID: 17917016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune reconstitution and recovery of FOXP3 (forkhead box P3)-expressing T cells after transplantation for IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome.
    Zhan H; Sinclair J; Adams S; Cale CM; Murch S; Perroni L; Davies G; Amrolia P; Qasim W
    Pediatrics; 2008 Apr; 121(4):e998-1002. PubMed ID: 18316354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, Immunological, and Molecular Heterogeneity of 173 Patients With the Phenotype of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (IPEX) Syndrome.
    Gambineri E; Ciullini Mannurita S; Hagin D; Vignoli M; Anover-Sombke S; DeBoer S; Segundo GRS; Allenspach EJ; Favre C; Ochs HD; Torgerson TR
    Front Immunol; 2018; 9():2411. PubMed ID: 30443250
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical Heterogeneity of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome: A French Multicenter Retrospective Study.
    Duclaux-Loras R; Charbit-Henrion F; Neven B; Nowak J; Collardeau-Frachon S; Malcus C; Ray PF; Moshous D; Beltrand J; Goulet O; Cerf-Bensussan N; Lachaux A; Rieux-Laucat F; Ruemmele FM
    Clin Transl Gastroenterol; 2018 Nov; 9(10):201. PubMed ID: 30385752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome.
    Uzel G; Sampaio EP; Lawrence MG; Hsu AP; Hackett M; Dorsey MJ; Noel RJ; Verbsky JW; Freeman AF; Janssen E; Bonilla FA; Pechacek J; Chandrasekaran P; Browne SK; Agharahimi A; Gharib AM; Mannurita SC; Yim JJ; Gambineri E; Torgerson T; Tran DQ; Milner JD; Holland SM
    J Allergy Clin Immunol; 2013 Jun; 131(6):1611-23. PubMed ID: 23534974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical features and genetic analysis of a child with late-onset immune dysregulation, polyendocrinopathy, enteropathy, X-Linked syndrome].
    Zhou F; Wang R; Yu Z; Li S; Li X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Mar; 38(3):255-259. PubMed ID: 33751536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: A systematic review.
    Park JH; Lee KH; Jeon B; Ochs HD; Lee JS; Gee HY; Seo S; Geum D; Piccirillo CA; Eisenhut M; van der Vliet HJ; Lee JM; Kronbichler A; Ko Y; Shin JI
    Autoimmun Rev; 2020 Jun; 19(6):102526. PubMed ID: 32234571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From autoimmune enteropathy to the IPEX (immune dysfunction, polyendocrinopathy, enteropathy, X-linked) syndrome.
    Blanco Quirós A; Arranz Sanz E; Bernardo Ordiz D; Garrote Adrados JA
    Allergol Immunopathol (Madr); 2009; 37(4):208-15. PubMed ID: 19912978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel variant of FOXP3 resulting in severe immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome highlights potential pitfalls of molecular testing.
    Kirchner A; Sanchez IM; Zalan A; Bhat G; Bain M
    Pediatr Dermatol; 2022 May; 39(3):483-485. PubMed ID: 35191551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical late-onset severe gastritis in immune dysregulation, polyendocrinopathy, enteropathy, and X-linked (IPEX) syndrome: 2 case reports.
    Fang Y; Luo Y; Lou J; Chen J
    Medicine (Baltimore); 2021 Jan; 100(3):e24318. PubMed ID: 33546062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.
    d'Hennezel E; Bin Dhuban K; Torgerson T; Piccirillo CA
    J Med Genet; 2012 May; 49(5):291-302. PubMed ID: 22581967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IPEX syndrome from diagnosis to cure, learning along the way.
    Bacchetta R; Roncarolo MG
    J Allergy Clin Immunol; 2024 Mar; 153(3):595-605. PubMed ID: 38040040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous manifestations of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome.
    Halabi-Tawil M; Ruemmele FM; Fraitag S; Rieux-Laucat F; Neven B; Brousse N; De Prost Y; Fischer A; Goulet O; Bodemer C
    Br J Dermatol; 2009 Mar; 160(3):645-51. PubMed ID: 18795917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic associations of a mild phenotype of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome.
    De Benedetti F; Insalaco A; Diamanti A; Cortis E; Muratori F; Lamioni A; Carsetti R; Cusano R; De Vito R; Perroni L; Gambarara M; Castro M; Bottazzo GF; Ugazio AG
    Clin Gastroenterol Hepatol; 2006 May; 4(5):653-9. PubMed ID: 16630773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.